Advanced Accelerator Applications Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1,023

Employees

  • Latest Deal Type
  • M&A
  • (Rumor/Speculation)

  • Investors
  • 1

Advanced Accelerator Applications General Information

Description

Developer of nuclear medicine focused on delivering targeted radioligand therapies and precision imaging radioligands for oncology. The company's medicine focuses on neuroendocrine and prostate cancer and is engaged in developing and delivering medicines and therapies used in clinical oncology, cardiology, neurology and infectious or inflammatory diseases.

Contact Information

Website
www.adacap.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Corporate Office
  • 8 rue Henri Sainte-Claire Deville
  • 10150 Rueil-Malmaison
  • France
+33 01 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Accelerator Applications Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 06-Oct-2023 Rumor/Speculation Profitable
7. Merger/Acquisition 22-Jan-2018 00.00 00000 00.00 Completed Profitable
6. IPO 16-Nov-2015 000.00 00000 00000 Completed Clinical Trials - Phase 3
5. Later Stage VC 23-Jun-2015 000.00 00000 00000 Completed Clinical Trials - Phase 3
4. Later Stage VC 17-Feb-2014 000.00 00000 00000 Completed Generating Revenue
3. Later Stage VC 25-Jul-2011 000.00 000.00 00000 Completed Generating Revenue
2. Later Stage VC 30-Apr-2009 $23.7M $31.9M 00000 Completed Generating Revenue
1. Later Stage VC 10-Nov-2006 $8.25M $8.25M 000.00 Completed Startup
To view Advanced Accelerator Applications’s complete valuation and funding history, request access »

Advanced Accelerator Applications Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
Ordinary Shares 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary Shares 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary Shares 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary Shares 3,500,000 $0.111756 $1.12 $1.12 1x $1.12 5.22%
Ordinary Shares 5,680,000 $0.111756 $0.59 $0.59 1x $0.59 8.48%
To view Advanced Accelerator Applications’s complete cap table history, request access »

Advanced Accelerator Applications Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of nuclear medicine focused on delivering targeted radioligand therapies and precision imaging radioligands fo
Drug Discovery
Rueil-Malmaison, France
1,023 As of 2023
00000
000000&0

000000

e eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
0000000000000
San Diego, CA
000 As of 0000
00000
0000000000.

000000

ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in vo
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Advanced Accelerator Applications Competitors (55)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sorrento Therapeutics Formerly VC-backed San Diego, CA 000 00000 0000000000.
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
NexImmune Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
Inhibrx Formerly VC-backed La Jolla, CA 000 00000 000000&0 00000
Vyriad Venture Capital-Backed Rochester, MN 00 00000 00000000000 00000
You’re viewing 5 of 55 competitors. Get the full list »

Advanced Accelerator Applications Patents

Advanced Accelerator Applications Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3215723-A1 Diagnostic methods of prostate cancer Pending 02-Apr-2021 00000000000
EP-4313175-A1 Diagnostic methods of prostate cancer Pending 02-Apr-2021 00000000000
EP-4260346-A1 Method for producing high purity and high specific activity radionuclides Pending 10-Dec-2020 000000000
US-20240029909-A1 Method for producing high purity and high specific activity radionuclides Pending 10-Dec-2020 00000000
EP-4204021-A1 Method of treating psma-expressing cancers Pending 31-Aug-2020 A61P35/00
To view Advanced Accelerator Applications’s complete patent history, request access »

Advanced Accelerator Applications Executive Team (15)

Name Title Board Seat Contact Info
Sidonie Golombowski-Daffne Ph.D Chairperson & President
Caio Kugelmas Managing Director & General Manager
Giovanni Cerutti MD Commercial Head Italy, AAA Molecular Imaging
You’re viewing 3 of 15 executive team members. Get the full list »

Advanced Accelerator Applications Board Members (14)

Name Representing Role Since
Andrea Ruben Levi Self Board Member 000 0000
Eugenio Aringhieri Self Board Member 000 0000
Muriel de Szilbereky Self Independent Director 000 0000
Raffaele Petrone Self Board Member 000 0000
Sidonie Golombowski-Daffne Ph.D Advanced Accelerator Applications Chairperson & President 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Advanced Accelerator Applications Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced Accelerator Applications Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Adage Capital Management Hedge Fund Minority 000 0000 000000 0
Carpefin Corporation Minority 000 0000 000000 0
Dompé Corporation Minority 000 0000 000000 0
Expansinvest PE/Buyout Minority 000 0000 000000 0
HBM Healthcare Investments Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »

Advanced Accelerator Applications Investments & Acquisitions (15)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Altheia Science 19-Dec-2018 00000 0000 000.00 Biotechnology
F-18 radiopharmaceutical Production Sites 26-May-2016 000000000 Buildings and Property 000000 00
IDB Holland 07-Jan-2016 0000000000 Biotechnology 0000000 0
Atreus Pharmaceuticals 05-Jan-2015 000000000 000.00 Biotechnology 0000000 0
Umbra Medical 01-Dec-2014 Corporate 00.00 Biotechnology
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Advanced Accelerator Applications Subsidiaries (3)

Company Name Industry Location Founded
Umbra Medical Biotechnology Cologne, Germany 2008
Imaging Equipment Distributors (Healthcare) Chilcompton, United Kingdom 0000
Biosynthema Biotechnology Saint Louis, MO 0000
To view Advanced Accelerator Applications’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »